PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1425409-5	1992	In females maintained on 17 beta-estradiol only and killed between 1400-1530 h, only 1.3 +/- 0.7% of GnRH neurons contained FOS, while treatment with estradiol benzoate/progesterone increased FOS expression significantly to 31.7 +/- 8.5% in the same time period.	Progesterone	169-181	FBJ osteosarcoma oncogene	Mus musculus	192-195	
26878066-6	2016	In a number of instances JUNB and c-FOS expression paralleled the decreases in receptor number and progesterone production, while in some cases these early response genes were affected little if at all by the changes in receptor number.	Progesterone	99-111	FBJ osteosarcoma oncogene	Mus musculus	34-39	
22577852-4	2012	Treatment with EB and progesterone induced significant Fos/GnRH double-labelling and, consequently, an LH surge in female WT and in ArKO mice of both sexes but not in male WT mice.	Progesterone	22-34	FBJ osteosarcoma oncogene	Mus musculus	55-58	
19847363-8	2009	Cyclins and cyclin-dependent kinases, as well as proto-oncogenes (c-myc, c-fos) were up-regulated when cells were treated with progesterone.	Progesterone	127-139	FBJ osteosarcoma oncogene	Mus musculus	73-78	
1511103-3	1992	Priming with 2 mg progesterone (P4) for 3 days prior to the administration of 100 ng E2 or giving 100 ng E2 and 2 mg P4 concomitantly induced Fos in the luminal and glandular epithelium with enhanced staining in stromal cells.	Progesterone	18-30	FBJ osteosarcoma oncogene	Mus musculus	142-145	
1915105-4	1991	In addition, the level of expression of c-fos by the estrogen- and progesterone-induced murine cervicovaginal LJ6195 tumor was similar to that in the normal vaginal tract following estradiol stimulation and was not regulated by estradiol.	Progesterone	67-79	FBJ osteosarcoma oncogene	Mus musculus	40-45